The antidepressant Prozac may help to curb disease activity in the relapsing remitting form of multiple sclerosis (MS), reveals preliminary research published ahead of print in the Journal of ...
The antidepressant Prozac may help to curb disease activity in the relapsing remitting form of multiple sclerosis, reveals preliminary research in the Journal of Neurology Neurosurgery and Psychiatry.
... work. Relatively new drugs now help some patients, but not others, with the most common form of multiple sclerosis. That may be because patients with the same symptoms experience different types of ...
In an animal model of multiple sclerosis (MS), neuroradiologists and neurologists of the University hospitals of Heidelberg and Würzburg have been able to visualize inflammatory tissue damage, most of ...
Canada has one of the highest rates of multiple sclerosis in the world, according to an international survey.
The majority of children vaccinated against hepatitis B are not at an increased risk of developing multiple sclerosis (MS), according to a study in Neurology.
New research may help reveal why different parts of the brain can come under attack in patients with multiple sclerosis (MS). According to a new study in mice with an MS-like ...
... and the Head of the Department of Clinical Neurosciences at the University of Cambridge.
Multiple sclerosis is an autoimmune disease which is caused by the body's immune system attacking nerve ...
... allow development of better models for determining prognosis and treating many neurological diseases such as multiple sclerosis."
This latest research bolsters Russell's central hypothesis about MS ...
A new study highlights the role of a charge-switching enzyme in nervous system deficits characteristic of multiple sclerosis and other related neurological illness. Multiple sclerosis (MS) is one of ...
Regular magnetic resonance imaging (MRI) evaluations show that only about half of patients with multiple sclerosis achieve and sustain a response to treatment with interferon beta over three years, ...
Regular magnetic resonance imaging evaluations show that only about half of patients with multiple sclerosis achieve and sustain a response to treatment with interferon beta over three years, ...
... Tysabri, is the first
drug that the National Institute for Clinical Excellence has
approved for multiple sclerosis. MS is a disease of the central
nervous system which can progress from tingling and ...
... , the immune system directs its defence against itself, with fatal consequences. In the case of multiple sclerosis, a chronic, inflammatory autoimmune disease, the immune system attacks the protective ...
... , the immune system directs its defence against itself, with fatal consequences. In the case of multiple sclerosis, a chronic, inflammatory autoimmune disease, the immune system attacks the protective ...
